Case Studies


3-D Bioprinting

Cancer Treatment through Novel Biomarkers

Tumors, accounting for the second largest cause of death, are characterized by uncontrolled cell growth. Tumor cells develop immune-suppressing chemicals in the initial stages and migrate to other cells and organs over time. Around 200 existing tumor types exist, and according to the World Health Organization (WHO), only 30-50% are curable only if diagnosed early. Cancer is usually asymptomatic in stage I/II and, therefore, complex to diagnose. Biomarkers can be potentially used in identifying tumor-causing cells that can, later on, help suppress the life-threatening disease.

At DelveInsight, we focus on providing one-stop solutions to our clients to accelerate the growth of their businesses and add considerable value to the healthcare domain. DelveInsight stands among the leading companies that aid in the successful growth of various Healthcare Industries by providing the best consulting and forecasting strategies.

We have a robust team of professionals, including experienced consultants and KOLs, who have the solution to every stubborn complexity.

Wide Range of Solutions

We provide handcrafted solutions to our clients, personalized as per their demands.

In-depth Attention

We hold considerable expertise in the healthcare domain. Our professionals offer simplified, dynamic, innovative insights and indication-oriented reports and services.

Book Your Appointment

Get the best business-oriented solutions in the oncology segment by reaching out to the best consultancy and forecasting service provider.